AGRX
Agile Therapeutics Inc

18,050
Loading...
Loading...
News
all
press releases
Agile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Update
Agile Therapeutics, Inc. (NASDAQ:AGRX Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 361,300 shares, a...
Zolmax·1y ago
News Placeholder
More News
News Placeholder
Q4 2023 Agile Therapeutics Inc Earnings Call Transcript
Related Stocks: OTCPK:AGRX...
GuruFocus·1y ago
News Placeholder
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·1y ago
News Placeholder
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript
Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript...
SeekingAlpha·1y ago
News Placeholder
Agile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Agile Therapeutics Q4 2023 Earnings Preview
Agile Therapeutics Q4 2023 Earnings Preview...
SeekingAlpha.com: All News·1y ago
News Placeholder
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday. read more...
Benzinga·1y ago
News Placeholder
Agile Therapeutics Announces Delisting from Nasdaq
PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ( Agile Therapeutics or the Company ), a women's healthcare company, today announced that the Company...
Globe Newswire·1y ago
News Placeholder
Earnings Scheduled For March 22, 2024
Companies Reporting Before The Bell Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. read more...
Benzinga·1y ago
News Placeholder
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Live Conference Call and Webcast at 8:30 a.m. ETPRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Globe Newswire·1y ago

Latest AGRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.